Skip to content

Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)45–56
Number of pages12
JournalJournal of Pathology
Issue number1
Early online date16 Nov 2016
DateAccepted/In press - 21 Sep 2016
DateE-pub ahead of print - 16 Nov 2016
DatePublished (current) - 16 Dec 2016


Age-related macular degeneration (AMD) is the leading cause of central vision loss worldwide. Loss of retinal pigment epithelium (RPE) is a major pathological hallmark in AMD with or without pathological neovascularization. Although activation of the immune system is implicated in disease progression, pathological pathways remain diverse and unclear. Here, we report an unexpected protective role of a pro-inflammatory cytokine, interleukin-33 (IL-33) in ocular angiogenesis. IL-33 and its receptor (ST2) are expressed constitutively in human and murine retina and choroid. When RPE was activated, IL-33 expression was markedly elevated in vitro. We found that IL-33 regulated tissue remodelling by attenuating wound-healing responses, including reduction in migration of choroidal fibroblasts and retinal microvascular endothelial cells, and inhibition of collagen gel contraction. In vivo, local administration of recombinant IL-33 inhibited murine choroidal neovascularization (CNV) formation, a surrogate of human neovascular AMD, and this effect was ST2-dependent. Collectively, these data demonstrate IL-33 as a potential immunotherapy and distinguishes pathways for subverting AMD pathology.

    Research areas

  • IL-33, AMD, RPE, angiogenesis, wound healing

Download statistics

No data available



  • Full-text PDF (final published version)

    Rights statement: This is the final published version of the article (version of record). It first appeared online via Wiley at DOI: 10.1002/path.4816. Please refer to any applicable terms of use of the publisher.

    Final published version, 3 MB, PDF document

    Licence: CC BY-NC-ND


View research connections

Related faculties, schools or groups